Filing Details
- Accession Number:
- 0001376339-25-000027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-12 19:56:49
- Reporting Period:
- 2025-03-10
- Filing Date:
- 2025-03-12
- Accepted Time:
- 2025-03-12 19:56:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1376339 | Mimedx Group Inc. | MDXG | Surgical & Medical Instruments & Apparatus (3841) | 262792552 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1796044 | Iv Frank William Hulse | 1775 West Oak Commons Court Ne Marietta GA 30062 | General Counsel And Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-10 | 81,446 | $7.80 | 494,774 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | $8.30 | 2032-03-03 | 108,432 | 108,432 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2032-03-03 | 108,432 | 108,432 | Direct |
Footnotes
- The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $7.74 to $7.96, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The exercise price of the Stock Options awarded on March 3, 2025 as stated in the Reporting Person's Form 4 filed March 5, 2025 inadvertently included a typographical error. This Form 4 accurately states the exercise price for the Stock Options awarded to the Reporting Person on March 3, 3025.
- The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement..